Valeant forms committee on drug prices

jeudi, 12 mai 2016

LAVAL, Que. - Embattled drug manufacturer Valeant Pharmaceuticals International (TSX:VRX) is revamping the way it prices drugs. 

Scientific basis for laws on marijuana, driving questioned - The Northern View

mardi, 10 mai 2016

 The Northern View -WASHINGTON — Six states that allow marijuana use have legal tests to determine driving while impaired by the drug that have no scientific basis, according to a study by the nation's largest automobile club that calls for scrapping those laws. 

Canadian Employers Will Face a $5.6 Billion Price Tag for Specialty Drugs Within the Next Five Years

mardi, 10 mai 2016

Le Lezard (EN) - Express Scripts Canada, one of the country's leading providers of health benefits management services, today announced the results of its annual Drug Trend Report. 

Germany To Legalize Medical Marijuana Next Year

dimanche, 8 mai 2016

IFL Science - Germany is set to become the latest country to legalize the use of cannabis for medicinal purposes, with the nation’s health minister confirming earlier this week that the German cabinet had approved the move. 

Valeant Pharmaceuticals announces shakeup on its board of directors

vendredi, 6 mai 2016

Valeant Pharmaceuticals is shaking up its board of directors, with half of them not standing for re-election, the Quebec-based drugmaker announced Friday. 

Concordia Healthcare: Diving deep into claims of sky high prices

vendredi, 6 mai 2016

BNN - Business News Network - Anyone with a passing interest in healthcare knows the practice of drug price increases has come under scrutiny lately. Concerns around this scrutiny evolving into new regulations or legal troubles have wiped out stock values in the process. 

FDA takes significant steps to protect Americans from dangers of tobacco through new regulation

jeudi, 5 mai 2016

Le Lezard (EN) - The U.S. Food and Drug Administration finalized a rule extending its authority to all tobacco products, including e-cigarettes, cigars, hookah tobacco and pipe tobacco, among others.  

Warren Buffett calls Valeant strategy 'flawed'

lundi, 2 mai 2016

Toronto - CBC News - Investor Warren Buffett said Berkshire Hathaway has called the business model of Valeant Pharmaceuticals flawed and panned the company's leadership. 

Cipher Pharmaceuticals Acquires Worldwide Rights to Dalhousie University's Investigational Tattoo Removal Cream

lundi, 2 mai 2016

 Le Lezard (EN)Cipher Pharmaceuticals Acquires Worldwide Rights to Dalhousie University's Investigational Tattoo Removal Cream 

Displaying results 91-99 (of 99)
 |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 >  >|

2020 Member Forum

15 septembre 2020
CAPDM Members: Please Log In to obtain member rate


Boot Camp

25 novembre 2020


Executive Conference

13 - 14 janvier 2020
Hôtel Marriott Terminal Aéroport de Montréal
Dorval, QC


Annual Conference

3 - 6 mai 2020
Nashville, Tennessee